Vesalius Cardiovascular Revenue

Biotechnology Research • Vancouver, British Columbia, Canada • 11-20 Employees

Vesalius Cardiovascular revenue & valuation

Annual revenue	$1,112,215
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$3,600,000
Total funding	$5,272,000

Key Contacts at Vesalius Cardiovascular

Vincent Ledoux

Chief Executive Officer

Ryan Harrington

Director Of Engineering

Peter Skarsgard

Co-Founder, Chief Medical Officer

Company overview

Headquarters	210 W Broadway, 200, Vancouver, British Columbia V5Y3W2, CA
Phone number	+16045596162
Website	vesaliuscardio.com
NAICS	541714
SIC	384
Keywords	Medical Devices, Biotech, Biomedical, Catheter
Founded	2016
Employees	11-20
Socials

Vesalius Cardiovascular Email Formats

Vesalius Cardiovascular uses 2 email formats. The most common is {first initial} (e.g., j@vesaliuscardio.com), used 50% of the time.

Format	Example	Percentage
{first initial}	j@vesaliuscardio.com	50%
{first name}	john@vesaliuscardio.com	50%

About Vesalius Cardiovascular

Vesalius Cardiovascular is a Canadian medical device company founded in 2016 in Vancouver, Canada. The company specializes in designing and developing biomedical devices for the treatment of cardiovascular disease, specifically mitral valve regurgitation (MR). We are clinical. Our devices is introduced percutaneously (transfemoral/transseptal) to the heart, eliminating the need for open heart surgery and the related risks. The procedure can be performed by a Cardiovascular Interventionalist (Cardiologist or Cardiac Surgeon). Vesalius Cardiovascular is the result of several years of intensive private research and investigation, and advanced biomedical engineering. The inventor behind Vesalius Cardiovascular is Dr. Peter Skarsgard, a Vancouver-based Cardiac Surgeon, and Head of the Division of Cardiovascular Surgery at Vancouver General Hospital. Vesalius Cardiovascular has developed a biomedical device that can be introduced percutaneously (transfemoral/transseptal) to the heart, for the treatment of Degenerative MR (DMR). The principles of surgical mitral valve repair are utilized, but sternotomy, heart-lung bypass, and cardiac arrest - components of an open heart operation - are not required.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Entry

Senior

C-Suite

Employees by Department

Vesalius Cardiovascular has 13 employees across 4 departments.

Departments

Number of employees

Funding Data

Explore Vesalius Cardiovascular's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2021-07-30	4	$5,000,000
2022-02-24	1	$272,000

Funding Insights

$5,272,000

Total funding amount

$272,000

Most recent funding amount

Number of funding rounds

Vesalius Cardiovascular Tech Stack

Discover the technologies and tools that power Vesalius Cardiovascular's digital infrastructure, from frameworks to analytics platforms.

reCAPTCHA

Security

ElementsKit

WordPress plugins

Elementor Header & Footer Builder

WordPress plugins

Site Kit

Analytics

jQuery UI

JavaScript libraries

Google Maps

Maps

Hello Elementor

WordPress themes

Elementor

Page builders

jQuery Migrate

JavaScript libraries

Apache HTTP Server

Web servers

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

Frequently asked questions

Vesalius Cardiovascular is located in Vancouver, British Columbia, CA.

You can reach Vesalius Cardiovascular at +16045596162.

Vesalius Cardiovascular generates an estimated annual revenue of $1,112,215. This revenue figure reflects the company's market position and business performance in its industry.

Vesalius Cardiovascular has an estimated valuation of $3,600,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Vesalius Cardiovascular was founded in 2016, making it 10 years old. The company has established itself as a significant player in its industry over this time.

Vesalius Cardiovascular has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Vesalius Cardiovascular has raised a total of $5,272,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Vesalius Cardiovascular

Vincent Ledoux

Chief Executive Officer

Ryan Harrington

Director Of Engineering

Peter Skarsgard

Co-Founder, Chief Medical Officer

4.8

40,000 users